{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":25,"n_cols":5,"rows_kept":25,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[14,2,14,3],[15,2,15,3],[19,2,19,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910785365203321"]
[null,null,"Titolo",null,"Cardiovascular effects of inhaled ultrafine and nanosized particles [[electronic resource] /] / edited by Flemming R. Cassee, Nicholas L. Mills, David Newby"]
[null,null,"Pubbl/distr/stampa",null,"Hoboken, N.J., : John Wiley, c2011"]
[null,null,"ISBN",null,"0-470-92277-X"]
[{"$nulls":4},"1-282-88900-1"]
[{"$nulls":4},"9786612889004"]
[{"$nulls":4},"0-470-91091-7"]
[{"$nulls":4},"0-470-91090-9"]
[null,null,"Descrizione fisica",null,"1 online resource (608 p.)"]
[null,null,"Disciplina",null,"616.1/2071"]
[null,null,"Soggetti",null,"Heart - Toxicology"]
[{"$nulls":4},"Air - Pollution - Toxicology"]
[{"$nulls":4},"Nanoparticles - Toxicology"]
[{"$nulls":4},"Pulmonary toxicology"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"CARDIOVASCULAR EFFECTS OF INHALED ULTRAFINE AND NANOSIZED PARTICLES; CONTENTS; FOREWORD; PREFACE; THE EDITORS; CONTRIBUTORS; PART I: ISSUE FRAMING; CHAPTER 1: OVERVIEW; CHAPTER 2: ACUTE EFFECTS OF PARTICULATE MATTER ON THE RISK OF MYOCARDIAL INFARCTION; CHAPTER 3: CHRONIC EFFECTS OF AIR POLLUTION ON CARDIOVASCULAR HEALTH; PART II: EXPOSURE; CHAPTER 4: PARTICLE CHARACTERIZATION; CHAPTER 5: EXPOSURE ASSESSMENT FOR AMBIENT ULTRAFINE PARTICLES; CHAPTER 6: FROM EXPOSURE TO DOSE; CHAPTER 7: TRANSLOCATION OF INHALED NANOPARTICLES"]
[{"$nulls":4},"CHAPTER 8: ROLE OF CHEMICAL COMPOSITION IN DETERMINING THE CARDIOVASCULAR EFFECTS OF PARTICLESPART III: METHODOLOGY; CHAPTER 9: IN VITRO STUDIES; CHAPTER 10: EXPERIMENTAL STUDIES IN ANIMALS; CHAPTER 11: HUMAN EXPOSURE STUDIES; CHAPTER 12: PANEL STUDIES; PART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS A. ATHEROGENESIS; CHAPTER 13: PARTICULATES AND OXIDATIVE STRESS; CHAPTER 14: ROLE OF INFLAMMATION IN THE ATHEROGENIC EFFECTS OF PARTICULATE MATTER; CHAPTER 15: "]
[{"$nulls":4},"INHALED PARTICLES, POSTPRANDIAL LIPIDS, AND THEIR POSSIBLE CONTRIBUTION TO ATHEROGENESIS: THE TROJAN HORSE HYPOTHESIS"]
[{"$nulls":4},"CHAPTER 16: INHALED PARTICULATE MATTER AND ATHEROSCLEROSIS IN HUMANSPART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS B. VASCULAR DYSFUNCTION; CHAPTER 17: EFFECTS OF NANOPARTICLES ON THE PULMONARY VASCULATURE; CHAPTER 18: PARTICULATE MATTER, HYPERTENSION, AND THE METABOLIC SYNDROME; CHAPTER 19: PARTICLES AND THE VASCULAR ENDOTHELIUM; PART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS C. THROMBOSIS; CHAPTER 20: PARTICLES, COAGULATION, AND THROMBOSIS; CHAPTER 21: PARTICLES AND THE PATHOGENESIS OF ATHEROTHROMBOSIS"]
[{"$nulls":4},"PART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS D. ARRHYTHMIACHAPTER 22: PARTICLES AND THE AUTONOMIC NERVOUS SYSTEM; CHAPTER 23: AIR POLLUTION AND ARRHYTHMIA; PART V: ENVIRONMENTAL AND PUBLIC HEALTH POLICY; CHAPTER 24: RISK ASSESSMENT; CHAPTER 25: ENVIRONMENTAL REGULATION OF PARTICULATE MATTER; CHAPTER 26: FROM AMBIENT ULTRAFINE PARTICLES TO NANOTECHNOLOGY AND NANOTOXICOLOGY; INDEX; Color plate"]
[null,null,null,"Sommario/riassunto","This book assists scientists, toxicologists, clinicians, and public health regulators to understand the complex issues that determine the impact of air pollution on the cardiovascular system. It covers a range of relevant topics including particulate matter (PM) sources and characterization, methods of exposure, impact of PM on cells and systems, role of particles in the pathophysiology of cardiovascular disease, risk assessment, and potential environmental and therapeutic interventions."]